SCHEMBL2659000

SCHEMBL2659000

CC1(C)OB(c2cccc(-c3ccccn3)c2F)OC1(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 5/20 0.35
LMNA P02545 3/20 0.35
CCR1 P32246 2/20 0.35
CCR5 P51681 2/20 0.35
CCR8 P51685 2/20 0.35
CYP1A2 P05177 1/20 0.35
POLB P06746 1/20 0.35
METAP1 P53582 1/20 0.35
BLM P54132 1/20 0.35
HIF1A Q16665 1/20 0.35
DOHH Q9BU89 1/20 0.35
P4HTM Q9NXG6 1/20 0.35
SMN1; SMN2 Q16637 5/20 0.35
TP53 P04637 5/20 0.35
L3MBTL1 Q9Y468 3/20 0.35
MAPK1 P28482 2/20 0.35
ALOX15 P16050 2/20 0.35
HTT P42858 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
ALPL P05186 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20149142 0.87 KDM4E (0.41) KDM4ELMNACCR1CCR5CCR8
SCHEMBL31520280 0.87 KDM4E (0.41) KDM4ELMNACCR1CCR5CCR8
SCHEMBL30276915 0.87 KDM4E (0.41) KDM4ELMNACCR1CCR5CCR8
SCHEMBL2658180 0.81 KDM4E (0.35) KDM4ELMNACCR1CCR5CCR8
SCHEMBL21215474 0.80 KDM4E (0.34) KDM4ELMNACCR1CCR5CCR8
SCHEMBL22808280 0.79 PDK2 (0.37) KDM4ELMNACCR1CCR5CCR8
SCHEMBL20968600 0.78 LIPG (0.49) LPLLIPGCXCR2JAK2BTK
SCHEMBL9887332 0.77 BRD4 (0.39) KDM4ELMNACCR1CCR5CCR8
SCHEMBL31401292 0.77 LPL (0.37) LMNASMN1; SMN2TP53HTTGCK
SCHEMBL2659535 0.77 LPL (0.37) LMNASMN1; SMN2TP53HTTGCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2004043930-A1 QUINOLINE DERIVATIVES WHICH ENHANCE COGNITION VIA THE GABA-A RECEPTOR MERCK SHARP & DOHME LIMITED (GB) 2004-05-27 WO disclosed